Saddle Up: 'Casa De Mi Padre' Is One to See, Señor

Saddle up: 'Casa de mi Padre' is one to see, señor

Filed under: Boston Drug Use

The “narcos” use Armando's father's land to smuggle drugs into Los Estados Unidos and leave mangled corpses hanging around. Directed by Ferrell-era “Saturday Night Live” and “Funny or Die Presents…” alum Matt Piedmont, the film features Diego Luna as …
Read more on Boston Herald

 

Embera NeuroTherapeutics and Collaborators Publish Paper in Psychopharmacology

Filed under: Boston Drug Use

BOSTON & SHREVEPORT, La., Mar 16, 2012 (BUSINESS WIRE) — Embera NeuroTherapeutics Inc., a specialty pharmaceutical company developing novel treatments for smoking cessation and other addictions, announced today the publication of results from a …
Read more on MarketWatch (press release)

 

Study: Drug speeds recovery of patients with severe traumatic brain injury

Filed under: Boston Drug Use

By Chelsea Conaboy, Globe Staff The pace of recovery for patients with severe brain injuries that leave them in a vegetative state or with limited consciousness may be quickened with the use of a drug commonly used to treat Parkinson's disease, …
Read more on Boston.com (blog)

 


 

Without Bias – Bias Remembered – When Len Bias died, he forever altered our perception of casual drug use and became the tipping point of America’s drug crisis in the mid-80s.

 

Early Stage Clinical Development
Event on 2012-05-29 09:00:00

EARLY STAGE CLINICAL DEVELOPMENT

Minimize your drug attrition rates by improving translation from preclinical to clinical development
29-31 May 2012
Boston, MA

www.early-clinicaldevelopment.com

How innovative approaches to early stage clinical trial design can guarantee you late stage success

Now is the time for you to increase the efficiency of your early stage clinical development program. With rising R&D costs & decreasing approval rates, optimizing your approach to early stage clinical development has never been more important. Do you have a plan in place?

The Early Stage Clinical Development Summit will bring together the leading drug developers, service providers & clinicians to discuss how to identify the best candidates in your pipeline as early as possible, allowing you to make go/no-go decisions faster.

Confirmed speakers include:

  • Dr Laura Vessey, Associate Director, Early Clinical Development, Merck
  • Carl Alden, Vice President, Drug Safety, Millennium
  • Michael Wolf, Director, Clinical Development, Sanofi
  • Alan Xiao, Director Clinical Pharmacology, AstraZeneca
  • Jonathan Deutsch, Therapeutic Area Safety Head for Oncology, Johnson & Johnson
  • Johan Luthman, Vice President R&D, Merck
  • David Geho, Senior Biomarker and Experimental Medicine Leader, Roche
  • Mike Hale, Executive Director, Amgen

Attend this meeting and you will:

  • Learn how to design efficient strategies to successfully develop safety biomarkers as useful indicators of pharmacodynamic end points
  • Gain an industry perspective into how you can efficiently outsource your drug development program to minimize costs
  • Understand how using a data driven approach to drug development can help you to identify your go/no go targets earlier avoiding costly failures further down the pipeline
  • Discover how to accelerate PoC & make your early phase trials better indicators of later success
  • Evaluate various patient selection & recruitment strategies to increase phase I trial uptake & ensure the right patient for the right trial

The Early Stage Clinical Development Summit is being co-located with the Late Stage Product Development meeting.

Both will take place at PHASE, a 4 day Clinical Trial meeting in Boston. Featuring unparallelled networking opportunities and the chance to attend presentations from both meetings, PHASE offers you the chance to hear from industry leaders on the hottest topics in drug development.

For more information, simply:

Call: +1 212 537 5898
Email: [email protected]
View: www.early-clinicaldevelopment.com

at Boston
Boston
Boston, United States
CANCER VACCINES & ACTIVE IMMUNOTHERAPEUTICS 3RD ANNUAL SUMMIT
Event on 2012-06-26 08:30:00
CANCER VACCINES & ACTIVE IMMUNOTHERAPEUTICS 3RD ANNUAL SUMMIT
Approaches to Optimize Immune Response, Enhance Clinical Development & Drive Commercial Performance
26 – 28 June 2012
Boston, MA
www.cancervaccines-meeting.com

Unlock the potential of your anti-cancer drug.

Dendreon hit all the headlines when Provenge got approval. Then Ipilimumab. And just beneath the surface, a host of others are starting to make waves. With MAGE, PROSTVAC and several other products knocking on the door of market approval, what are you doing to ensure your drug reaches these heights?

Designed by Merck Serono, Immatics Biotechnologies, DCPrime, MedImmune, FDA, Oxford Biomedica and many others, the Cancer Vaccines & Active Immunotherapeutics 3rd Annual Summit will bring together key opinion leaders to discuss and debate different approaches to help you navigate the clinic, boost the immune response and jump over every regulatory hurdle en route to market.

With a strong focus on combination approaches, novel adjuvants and immunomodulators, you will leave the meeting armed with the best strategies to develop successful anti-cancer drugs. Our other Cancer Vaccines meetings were acclaimed by delegates for doing just that.

What will be covered on the agenda?

•Hear case studies on a diverse range of immunomodulators and adjuvantswhich mediate meaningful anti-tumor clinical responses

•Discover how to enhance the potency of your cancer vaccine by combining it with other types of therapy

•Learn how to design clinical studies to maximize the potential of cancer immunotherapeutic candidates and implement strategies to identify the patients that will benefit

•Get advice from the FDA on how to manage regulatory obstacles to ensure successful cancer vaccine development

•Find out how to use biomarkers to predict the efficacy of your cancer immunotherapeutic

•Overcome challenges faced during development of cancer vaccines that targetalternate routes of immunization

•Implement an evidence-based medicine approach to ensure that your cancer immunotherapeutic demonstrates value, affordability and a compelling clinical risk to benefit balance

Why attend?

•The meeting focuses on delivering content that is of practical value, pushing existing boundaries in the cancer vaccine space and helping to grow your business and research

•Meet and network with the key players in the field and leave the conference with an array of new ideas and contacts to take back to your organization

For more information, simply:
Call: +1 212 537 5898
Email: [email protected]
View: www.cancervaccines-meeting.com

at Sheraton Boston
39 Dalton Street
Boston, United States
Playin’ Dead – New England’s Premier Grateful Dead Tribute, 6th Annual Ship Of Fools Grateful Dead Concert Cruise!
Event on 2012-08-17 20:00:00

Playin' Dead – New England's Premier Grateful Dead Tribute

Playin' Dead brings together amazing talent to pay tribute to Grateful Dead music. Rife with passion and spirit, the band brings the Dead's music to life with dedication and style. Playin' Dead band members have played with the Dark Star Orchestra, Uncles Johns Band (Florida), Laughing Water, and Colonel Mustard. They used to be called Electric Hummus. Dont miss the next show!!

6th Annual Ship Of Fools Grateful Dead Concert Cruise!

GREETINGS ROCK ON! CONCERT CRUISER! Thanks for coming out and partying with us! We know of no other experience that rivals our awesome boat parties for unadulterated semi naked summer fun. We know you have a lot of choices for your entertainment dollars, so we are pumped you chose to rock out with us! Rock On! Concert Cruises are on Mass Bay Lines and depart from Rowes Wharf at The Boston Harbor Hotel Atlantic Avenue – CRUISES ARE RAIN OR SHINE. There is Parking @ INTERNATIONAL PLACE GARAGE across from the Hotel after 6pm, get your parking pass stamped at Box Office. By T, Red Line to South Station – it's 1/4 mile up Atlantic Ave or Blue Line to Aquarium – it's 1/4 mile down Atlantic Ave. Boarding Begins at 7:15 – BOAT DEPARTS AT 8pm SHARP. DON'T BE LATE!!! You do not want to be that guy/gal who watches the party float away. It's a cash bar so stop at an ATM machine on your way, light snacks and hot dogs available on the boat. Pick Up WillCall Tix at Mass Bay Lines Box Office Gate C behind the Boston Harbor Hotel. You will be subject to a SECURITY CHECK / LIGHT PAT DOWN outside drinks, flasks and contraband are not allowed. Drugs are Bad mmm'kay? Stick em where the sun don't shine or expect them to be confiscated.

at Rock On! Concert Cruise Aboard The Mass Bay Lines MV New Boston

Boston, United States